InvestorsHub Logo
Followers 829
Posts 119686
Boards Moderated 16
Alias Born 09/05/2002

Re: stockbettor post# 689

Tuesday, 11/11/2014 5:40:43 PM

Tuesday, November 11, 2014 5:40:43 PM

Post# of 2978
Failure rates ought to be lower on Harvoni or ABBV/ENTA's regimen.

To the extent that approximately 20% of real-world Sovaldi patients were not cured, that adds to the pool of treatable second-line patients and is bullish for ENTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News